Gene · 9118
Papers2,019
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,019
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assay for evaluation of proarrhythmic effects of herbal products: Case study with 12 Evodia preparations. | Toxicol Rep | 2023 | 37213814 | PubTator, text mining | PubMed |
| Blood Based Biomarkers of Central Nervous System Involvement in Wilson's Disease. | Diagnostics (Basel) | 2023 | 37174946 | PubTator, text mining | PubMed |
| Symmetry Breaking of Human Pluripotent Stem Cells (hPSCs) in Micropattern Generates a Polarized Spinal Cord-Like Organoid (pSCO) with Dorsoventral Organization. | Adv Sci (Weinh) | 2023 | 37170679 | PubTator, text mining | PubMed |
| Bioinformatics approach to analyse COVID-19 biomarkers accountable for generation of intracranial aneurysm in COVID-19 patients. | Inform Med Unlocked | 2023 | 37159621 | PubTator, text mining | PubMed |
| Mechanisms underlying the antiarrhythmic effect of ARumenamide-787 in experimental models of the J wave syndromes and hypothermia. | PLoS One | 2023 | 37159454 | PubTator, text mining | PubMed |
| SGK1 inhibition attenuated the action potential duration in patient- and genotype-specific re-engineered heart cells with congenital long QT syndrome. | Heart Rhythm O2 | 2023 | 37124559 | PubTator, text mining | PubMed |
| Cardiomyocyte electrophysiology and its modulation: current views and future prospects. | Philos Trans R Soc Lond B Biol Sci | 2023 | 37122224 | PubTator, text mining | PubMed |
| Late sodium current in synergism with Ca2+/calmodulin-dependent protein kinase II contributes to β-adrenergic activation-induced atrial fibrillation. | Philos Trans R Soc Lond B Biol Sci | 2023 | 37122215 | PubTator, text mining | PubMed |
| Feedback contributions to excitation-contraction coupling in native functioning striated muscle. | Philos Trans R Soc Lond B Biol Sci | 2023 | 37122213 | PubTator, text mining | PubMed |
| ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr. | Pharmaceuticals (Basel) | 2023 | 37111245 | PubTator, text mining | PubMed |
| T-Cell Receptor Repertoire Characteristics Associated with Prognostic Significance in High-Grade Serous Ovarian Carcinoma. | Genes (Basel) | 2023 | 37107543 | PubTator, text mining | PubMed |
| Nano-DMS-MaP allows isoform-specific RNA structure determination. | Nat Methods | 2023 | 37106231 | PubTator, text mining | PubMed |
| Predicting individual-specific cardiotoxicity responses induced by tyrosine kinase inhibitors. | Front Pharmacol | 2023 | 37101545 | PubTator, text mining | PubMed |
| Sex differences in long QT syndrome. | Front Cardiovasc Med | 2023 | 37082456 | PubTator, text mining | PubMed |
| New in vitro multiple cardiac ion channel screening system for preclinical Torsades de Pointes risk prediction under the Comprehensive in vitro Proarrhythmia Assay concepta. | Korean J Physiol Pharmacol | 2023 | 37078300 | PubTator, text mining | PubMed |
| Immunomodulatory Properties of Vitamin D in the Intestinal and Respiratory Systems. | Nutrients | 2023 | 37049536 | PubTator, text mining | PubMed |
| Ion Channels as a Potential Target in Pharmaceutical Designs. | Int J Mol Sci | 2023 | 37047455 | PubTator, text mining | PubMed |
| Gigaxonin is required for intermediate filament transport. | FASEB J | 2023 | 37043392 | PubTator, text mining | PubMed |
| Microtubule plus-end tracking proteins: novel modulators of cardiac sodium channels and arrhythmogenesis. | Cardiovasc Res | 2023 | 37040608 | PubTator, text mining | PubMed |
| Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy. | Cell Stem Cell | 2023 | 37028405 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9118/papers?page=9